As previously reported by Metacrine, Inc. in its Current Report on Form 8-K dated February 17, 2022 and filed with the SEC on February 24, 2022, Patricia Millican notified the Board that she will resign from her position as the Company's Chief Financial Officer, principal financial officer and principal accounting officer, effective as of March 31, 2022, to pursue another opportunity.